According to DelveInsight’s analysis, The increasing demand for cataract surgery devices is largely driven by the rising prevalence of cataracts and vision impairment, along with the growing incidence of lifestyle-related conditions like hypertension and diabetes that contribute to cataract development. Additionally, the expanding elderly population, ongoing research and development, and technological advancements in product innovation are key factors supporting the market’s positive growth outlook between 2024 and 2030.
DelveInsight’s “Cataract Surgery Devices Market Insights, Competitive Landscape and Market Forecast-2030” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Cataract Surgery Devices companies actively working in the market.
To know more about why North America is leading the market growth in the Cataract Surgery Devices market, get a snapshot of the report Cataract Surgery Devices Market Trends
Cataract Surgery Devices Overview
Cataract surgery devices are specialized medical instruments and tools used to perform cataract surgery, a procedure to remove a clouded lens (cataract) from the eye and replace it with an artificial intraocular lens (IOL). These devices include phacoemulsification machines, IOLs, surgical lasers, ophthalmic viscoelastic devices (OVDs), and other instruments essential for precise and safe surgery. They help restore vision, improve quality of life, and are widely used due to the high prevalence of cataracts, especially among the aging population.
DelveInsight Analysis: The cataract surgery devices market was valued at approximately USD 7.73 billion in 2023 and is projected to grow at a CAGR of 5.50% from 2024 to 2030, reaching an estimated USD 10.66 billion by the end of the forecast period.
Cataract Surgery Devices Market Insights
Geographically, North America is projected to dominate the cataract surgery devices market in 2023, primarily due to the increasing cases of cataracts and vision-related disorders. Contributing risk factors such as diabetes, hypertension, and obesity are also prevalent in the region. Additionally, the expanding elderly population—more prone to cataracts—and ongoing technological advancements in device development are key elements supporting the market’s growth across North America.
To read more about the latest highlights related to Cataract Surgery Devices, get a snapshot of the key highlights entailed in the Cataract Surgery Devices
https://www.delveinsight.com/report-store/cataract-surgery-devices-market
Recent Developments in the Cataract Surgery Devices Market Report
In July 2024, Oertli Instrumente AG received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Faros anterior cataract surgery system. This high-performance surgical platform is designed to support procedures involving cataracts, vitreoretinal conditions, and glaucoma. It features sophisticated fluidics and vacuum control technologies, enabling enhanced surgical precision and smooth adaptation to different levels of cataract density.
In June 2024, Alcon obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its UNITY® Vitreoretinal Cataract System (VCS) and UNITY® Cataract System (CS). These systems are designed to provide improved precision during cataract surgeries involving vitreoretinal procedures.
In April 2023, Bausch + Lomb Corporation has introduced the StableVisc™ cohesive ophthalmic viscosurgical device (OVD) and the TotalVisc™ Viscoelastic System in the U.S. These products are developed to preserve space in the eye’s anterior chamber, aiding in the efficient removal and replacement of the clouded natural lens during cataract surgery.
Thus, owing to such developments in the market, rapid growth will be observed in the Cataract Surgery Devices market during the forecast period
Key Players in the Cataract Surgery Devices Market
Some of the key market players operating in the Cataract Surgery Devices market include- Alcon Inc., Johnson & Johnson Services, Inc., NIDEK CO., LTD., ZEISS Group, Bausch Health Companies Inc., Ziemer Ophthalmic Systems AG, Abbott Laboratories, HOYA Corporation, Aurolab, Hanita Lenses Ltd, Topcon Corporation, STAAR SURGICAL, Bohus BioTech AB, Eyekon Medical, CIMA Technology Inc., Medisonic Equipments Pvt. Ltd., Opthalmika Ltd, Lumenis Be Ltd., Essilor International, Oertli Instrumente AG, and others.
Which MedTech key players in the Cataract Surgery Devices market are set to emerge as the trendsetter explore @ Key Cataract Surgery Devices Companies
Analysis on the Cataract Surgery Devices Market Landscape
Within the product segment of the cataract surgery devices market, femtosecond lasers are anticipated to hold a substantial share throughout the forecast period, fueled by the rising volume of cataract surgeries worldwide. Data from the European Commission in 2023 highlights that cataract surgery was the most frequently performed surgical procedure, with 4.32 million surgeries carried out across Europe in 2021.
Key market leaders are concentrating on developing and commercializing advanced femtosecond lasers to enhance surgical accuracy, safety, and patient results. For example, in April 2023, Johnson & Johnson MedTech obtained FDA 510(k) clearance for its ELITA Femtosecond Laser system. This system features low energy per pulse and an ultra-fast laser repetition rate, aiming to reduce complications and improve visual recovery and patient outcomes. Innovations like these are anticipated to fuel considerable growth in the femtosecond laser segment, supporting the broader expansion of the cataract surgery devices market.
Scope of the Cataract Surgery Devices Market Report
Coverage: Global
Study Period: 2021–2030
Cataract Surgery Devices Market Segmentation By Product Type: Phacoemulsification Systems, Femtosecond Lasers, Intraocular Lenses, Ophthalmic Viscosurgical Devices, and Others
Cataract Surgery Devices Market Segmentation By End-User: Hospitals and Specialty Clinics
Cataract Surgery Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
Key Cataract Surgery Devices Companies: Alcon Inc., Johnson & Johnson Services, Inc., NIDEK CO., LTD., ZEISS Group, Bausch Health Companies Inc., Ziemer Ophthalmic Systems AG, Abbott Laboratories, HOYA Corporation, Aurolab, Hanita Lenses Ltd, Topcon Corporation, STAAR SURGICAL, Bohus BioTech AB, Eyekon Medical, CIMA Technology Inc., Medisonic Equipments Pvt. Ltd., Opthalmika Ltd, Lumenis Be Ltd., Essilor International, Oertli Instrumente AG, and others
Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Interested in knowing how the Cataract Surgery Devices market will grow by 2030? Click to get a snapshot of the Cataract Surgery Devices Market Analysis
Table of Contents
1
Cataract Surgery Devices Market Report Introduction
2
Cataract Surgery Devices Market Executive summary
3
Regulatory and Patent Analysis
4
Cataract Surgery Devices Market Key Factors Analysis
5
Porter’s Five Forces Analysis
6
COVID-19 Impact Analysis on Cataract Surgery Devices Market
7
Cataract Surgery Devices Market Layout
8
Global Company Share Analysis – Key Cataract Surgery Devices Companies
9
Company and Product Profiles
10
Project Approach
11
Cataract Surgery Devices Market Drivers
12
Cataract Surgery Devices Market Barriers
13
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Media ContactCompany Name: DelveInsightContact Person: Gaurav BoraEmail: Send EmailPhone: +14699457679Address:304 S. Jones Blvd #2432City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com/
